AstraZeneca spurns Pfizer’s Massive Offer


AstraZeneca deftly turned away an offer that many others probably wouldn’t have been able to resist. The $117 billion being given for a merger of the two companies by Pfizer was rejected. The...

A Look into the SEC’s clash with China auditors


On January 22, SEC Administrative Law Judge Cameron Elliot ordered that the China units of the global “Big Four” accounting firms should be suspended from auditing US-listed companies...